Graham Juan
SEC CIK 1879223 · EDGAR
BoughtSold
Most active insiders at CATX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lantheus Alpha Therapy, LLC | 10% | — | $1.27M |
| 2 | Lantheus Holdings, Inc. | 10% | — | $357.2K |
| 3 | Hunt Jonathan Robert | CAO | $22.3K | — |
| 4 | Williamson Robert F III | Dir | $19.9K | — |
Graham Juan made no open-market trades at CATX in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | 2025-03-28 | CATX | Perspective Therapeutics, Inc. | Graham Juan | CFO | P - Purchase | $2.25 | +33.3K | 35.4K | +1,649% | +$75.0K | |
| M | 2024-12-09 | 2024-12-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $0.34 | -2,512 | 165.9K | -1% | -$854.08 |
| M | 2024-09-09 | 2024-09-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $0.39 | -17.1K | 168.4K | -9% | -$6,675 |
| M | 2024-06-10 | 2024-06-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $1.18 | -19.0K | 185.7K | -9% | -$22.5K |
| M | 2024-03-08 | 2024-03-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $1.87 | -21.9K | 204.3K | -10% | -$40.9K |
| 2024-03-08 | 2024-03-06 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +781 | 205.1K | +0.4% | $0 | |
| D | 2024-02-23 | 2024-02-21 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +52.0K | 224.6K | +30% | $0 |
| M | 2023-12-11 | 2023-12-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $0.5826 | -16.7K | 172.6K | -9% | -$9,705 |
| M | 2023-09-08 | 2023-09-06+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $0.9782 | -1,807 | 190.4K | -0.9% | -$1,768 |
| D | 2023-09-01 | 2023-08-30 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +120.0K | 191.1K | +169% | $0 |
| M | 2023-06-09 | 2023-06-07 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | S - Sale | $16.99 | -1,785 | 71.8K | -2% | -$30.3K |
| M | 2023-03-10 | 2023-03-08+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | S - Sale | $20.54 | -7,661 | 72.9K | -10% | -$157.4K |
| M | 2023-03-10 | 2023-03-08 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +7,567 | 77.8K | +11% | $0 |
| D | 2023-02-23 | 2023-02-21 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +25.0K | 73.0K | +52% | $0 |
| M | 2022-12-15 | 2022-12-08 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | S - Sale | $14.89 | -5,741 | 50.6K | -10% | -$85.5K |
| MA | 2022-12-15 | 2022-12-09+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 48.0K | -4% | -$32.0K |
| M | 2022-12-14 | 2022-12-09+ | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 55.1K | -4% | -$32.0K |
| 2022-09-08 | 2022-09-07 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | F - Tax | $12.62 | -3,009 | 55.9K | -5% | -$38.0K | |
| D | 2022-02-16 | 2022-02-14 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +22.5K | 58.9K | +62% | $0 |
| D | 2021-09-09 | 2021-09-07 | KYNB | KYNTRA BIO, INC. | Graham Juan | CFO | A - Grant | $0.00 | +35.0K | 36.4K | +2,500% | $0 |
Purchase Sale Sale after option exercise All abbreviations